Discontinuation of Pneumocystis jirovecii pneumonia prophylaxis with CD4 count <200 cells/µL and virologic suppression: a systematic review.
<h4>Background</h4>HIV viral load (VL) is currently not part of the criteria for Pneumocystis jirovecii pneumonia (PCP) prophylaxis discontinuation, but suppression of plasma viremia with antiretroviral therapy may allow for discontinuation of PCP prophylaxis even with CD4 count <200...
Guardado en:
Autores principales: | Cecilia T Costiniuk, Dean A Fergusson, Steve Doucette, Jonathan B Angel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/021f1ae327ae4879ae3053e542ea241c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients
por: Su Hwan Lee, et al.
Publicado: (2017) -
Serum antibody levels to the Pneumocystis jirovecii major surface glycoprotein in the diagnosis of P. jirovecii pneumonia in HIV+ patients.
por: Kpandja Djawe, et al.
Publicado: (2010) -
Humoral immune responses to Pneumocystis jirovecii antigens in HIV-infected and uninfected young children with pneumocystis pneumonia.
por: Kpandja Djawe, et al.
Publicado: (2013) -
PNEUMOCYSTIS JIROVECII PNEUMONIA IN A HIV-NEGATIVE ADULT IN COVID-19 PANDEMIC
por: Muhammad Mohsin Sajjad, et al.
Publicado: (2020) -
Transmission and Colonization of <i>Pneumocystis jirovecii</i>
por: Cristian Vera, et al.
Publicado: (2021)